Have multiple conditions? Click here

New Clinical Trials for Lung Cancer

Although most lung cancer is caused by prolonged use of tobacco, there are other factors that may be a cause. These include genetics and exposure certain environmental elements like radon, asbestos or air pollution. More lung cancer clinical research is needed to completely understand this disease.
 
If you are a lung cancer survivor or are currently dealing with lung cancer please contact us about participating in a lung cancer clinical trial. These trials are always at no cost to you. You may be able to help us further our knowledge about causes and cures for lung cancer.
 

What is Lung Cancer?

Lung cancer occurs when there is uncontrolled cancer cell growth in the lungs. Metastasis is when these cells then grow beyond the lungs. Symptoms include shortness of breath, coughing (often with blood) and weight loss. There are two main types of lung cancer – small cell lung carcinoma and non-small cell lung carcinoma. The distinction is important because the type of lung cancer dictates the best treatment. Small cell lung carcinoma is the worst of the two conditions with very low survival rates. Non-small cell lung carcinoma is classified in stages 0 – 4, with four being the most advanced stage. The most common cause for lung cancer is smoking.
 

Lung Cancer Treatments

The course of action for lung cancer treatments depends on the type and severity of the cancer. Small cell lung carcinoma has usually progressed to the point where surgery is not an option, so it is treated using chemotherapy and radiation. In many non-small cell lung carcinomas surgery is possible to remove the cancerous cells. This is usually combined with radiation. Chest x-rays and then biopsies are used to determine the prognosis and implement a plan of action for the lung cancer treatment.

Have multiple conditions? Click here

Showing 1-100 of 4862
There are 4862 Lung Cancer Clinical Trials
Name City State Zip
Lung Cancer Clinical Trial Birmingham AL 35216
Lung Cancer Clinical Trial Birmingham AL 35216
Lung Cancer Clinical Trial Birmingham AL 35216
Phase II Avastin Trial for Stage IIIB/IV NSCLC Muscle Shoals AL 35661
Trial of Gemcitabine/Carboplatin With or Without Iniparib (SAR240550) (a PARP1 Inhibitor) in Subjects With Previously Untreated Stage IV Squamous Non-Small-Cell Lung Cancer (NSCLC) Muscle Shoals AL 35661
Once Weekly Radiation for Lung Cancer With Chemotherapy Mobile AL 36607
Hypo-Hyperfractionated Chest Radiation for Non Small Cell Lung Cancer With Taxotere/Xeloda Combination Chemotherapy Mobile AL 36685
Hypo-Hyperfractionated Chest Radiation for Non Small Cell Lung Cancer With Taxotere/Xeloda Combination Chemotherapy Mobile AL 36607
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery Mobile AL 36608
Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases Mobile AL 36608
Gemcitabine and Cisplatin in Treating Patients With Stage I Non-Small Cell Lung Cancer That Was Removed by Surgery Mobile AL 36608
Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer Mobile AL 36608
Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases Mobile AL 36608
Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer Mobile AL 36608
Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer Mobile AL 36608
Trial of Gemcitabine/Carboplatin With or Without Iniparib (SAR240550) (a PARP1 Inhibitor) in Subjects With Previously Untreated Stage IV Squamous Non-Small-Cell Lung Cancer (NSCLC) Huntsville AL 35805
Imetelstat as Maintenance Therapy After Initial Induction Chemotherapy in Non-small Cell Lung Cancer (NSCLC) Huntsville AL 35805
Airway Epithelium Gene Expression: IDE Birmingham AL 35294
Phase 2b Study of Cetuximab With Platinum-Based Chemo as First Line Treatment of Recurrent or Advanced NSCLC Birmingham AL
Bendamustine With Irinotecan Followed by Etoposide/Carboplatin for Patients With Extensive Stage Small Cell Lung Cancer Birmingham AL 35233
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy Birmingham AL
Chemotherapy or Observation in Treating Patients With Early Stage Non-Small Cell Lung Cancer Birmingham AL 35294
A Study of IMC-A12 (Cixutumumab) With and Without Other Standard Chemotherapies in Patients With Lung Cancer Who Have Not Received Chemotherapy Before Birmingham AL 35202
Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer: CLIA Birmingham AL 35294
Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin Birmingham AL
DNA Chip Based Prognosis of Lung Cancer Birmingham AL 35294
Trial of Gemcitabine/Carboplatin With or Without Iniparib (SAR240550) (a PARP1 Inhibitor) in Subjects With Previously Untreated Stage IV Squamous Non-Small-Cell Lung Cancer (NSCLC) Birmingham AL 35205
Imetelstat as Maintenance Therapy After Initial Induction Chemotherapy in Non-small Cell Lung Cancer (NSCLC) Birmingham AL 35216
A Study to Characterize the Safety, PK and Biological Activity of CC-930 in Idiopathic Pulmonary Fibrosis (IPF) Birmingham AL 35233
Pilot Study of Bisphosphonate Therapy (Zoledronic Acid) in Patients With Malignant Mesothelioma (UAB 0901) Birmingham AL 35233
Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer Anniston AL 36207
Chemotherapy or Observation in Treating Patients With Early Stage Non-Small Cell Lung Cancer Anniston AL 36207
A Randomized Trial Of PF-00299804 Taken Orally Versus Erlotinib Taken Orally For Treatment Of Advanced Non-Small Cell Lung Cancer That Has Progressed After One Or Two Prior Chemotherapy Regimen Alabaster AL 35007
An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene Alabaster AL 35007
An Investigational Drug, PF-02341066 Is Being Studied Versus Standard Of Care In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene Alabaster AL 35007
Erlotinib Is Being Studied With Or Without An Investigational Drug, PF-02341066, In Patients With Lung Cancer Alabaster AL 35007
Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases Fairbanks AK 99701
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery Anchorage AK 99508
Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases Anchorage AK 99508
Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer Anchorage AK 99508
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery Tucson AZ 85723
Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery Tucson AZ 85724
Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer Tucson AZ 85724
Ph II of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Treatment of Non-Small Cell Lung Cancer Tucson AZ 85715
Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer Tucson AZ 85723
Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer Tucson AZ 85724
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer Tucson AZ 85712
A Study of the HSP90 Inhibitor, STA-9090 in Subjects With Stage IIIB or IV Non-Small Cell Lung Cancer (NSCLC) Tucson AZ 85719
Eribulin Mesylate Administered in Combination With Pemetrexed Versus Pemetrexed Alone as Second Line Therapy in Patients With Stage IIIB or IV Nonsquamous Non Small Cell Lung Cancer Tucson AZ 85715
Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid Tumors Tucson AZ 85724
ARQ 197 Plus Erlotinib Versus Placebo Plus Erlotinib for the Treatment of Non-squamous, Non-small-cell Lung Cancer Tucson AZ 85745
ARQ 197 Plus Erlotinib Versus Placebo Plus Erlotinib for the Treatment of Non-squamous, Non-small-cell Lung Cancer Tucson AZ 85704
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery Scottsdale AZ 85259
A Study of Pemetrexed, Carboplatin and Bevacizumab in Patients With Nonsquamous Non-Small Cell Lung Cancer Scottsdale AZ 85259
Inositol in Preventing Lung Cancer in Current or Former Smokers With Bronchial Dysplasia Scottsdale AZ 85259
Quality of Life in Patients Undergoing Radiation Therapy for Primary Lung Cancer, Head and Neck Cancer, or Gastrointestinal Cancer Scottsdale AZ 85259
Cisplatin and Etoposide Phosphate With or Without GDC-0449 or Cixutumumab in Treating Patients With Extensive-Stage Small Cell Lung Cancer Scottsdale AZ 85259
Trial of Poor Performance Status Patients (ToPPS) Scottsdale AZ 85259
Study of Patients With Advanced Non-Small Cell Lung Cancer Scottsdale AZ 85259
A Study of Advanced or Metastatic Non-small Cell Lung Cancer Scottsdale AZ 85259
Temsirolimus and Bevacizumab in Treating Patients With Locally Advanced, Recurrent, Metastatic, or Progressive Endometrial Cancer, Ovarian Epithelial Cancer, Liver Cancer, Islet Cell Cancer, or Carcinoid Tumor Scottsdale AZ 85259
Seneca Valley Virus-001 After Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer Scottsdale AZ 85259
A Study of the HSP90 Inhibitor, STA-9090 in Subjects With Stage IIIB or IV Non-Small Cell Lung Cancer (NSCLC) Scottsdale AZ 85258
A Study in Second Line Non Small Cell Lung Cancer Scottsdale AZ 85259
Study of Erlotinib With or Without Investigational Drug (U3-1287) in Subjects With Advanced Non-small Cell Lung Cancer Scottsdale AZ 85258
Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases Phoenix AZ 85013
Airway Epithelium Gene Expression: IDE Phoenix AZ 85006
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy Phoenix AZ
Cancer Vaccine Study for Unresectable Stage III Non-small Cell Lung Cancer Mesa AZ 85202
Oral HYCAMTIN Plus Whole Brain Radiation Therapy In Treatment Of Brain Metastases Resulting From Non-Small Lung Cancer Glendale AZ 85304
Safety and Tolerability Study of GSK1120212, a MEK Inhibitor, in Combination With Docetaxel, Erlotinib, Pemetrexed, Pemetrexed + Carboplatin, or Nab-Paclitaxel Glendale AZ 85304
Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer Chandler AZ 85224
Study of Paclitaxel/Carboplatin With or Without Bavituximab in Previously Untreated Non Small-Cell Lung Cancer Chandler AZ 85224
Safety Study of Cetuximab in Combination With Cisplatin and Vinorelbine to Treat Advanced Non-small Cell Lung Cancer Casa Grande AZ 85122
Efficacy/Safety of Imprime PGG® Injection With Bevacizumab and Paclitaxel/Carboplatin in Patients With Untreated Advanced Non-Small Cell Lung Cancer (NSCLC) Springdale AR 72764
A Study of AUY922 in Non-small-cell Lung Cancer Patients Who Have Received Previous Two Lines of Chemotherapy Springdale AR 72764
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery Little Rock AR 72205
Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer Little Rock AR 72205
Phase 2b Study of Cetuximab With Platinum-Based Chemo as First Line Treatment of Recurrent or Advanced NSCLC Little Rock AR
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy Little Rock AR
Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer Little Rock AR 72205
Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer Little Rock AR
Effects of Essential Amino Acid Intake on Net Protein Synthesis in Weight-losing Non-small Cell Lung Cancer Patients Little Rock AR 72205
Erlotinib and Bevacizumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Jonesboro AR 72401
Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer Jonesboro AR 72401
Trial of Poor Performance Status Patients (ToPPS) Jonesboro AR 72401
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer Jonesboro AR 72401
Study of Paclitaxel/Carboplatin With or Without Bavituximab in Previously Untreated Non Small-Cell Lung Cancer Jonesboro AR 72401
A Study of the HSP90 Inhibitor, STA-9090 in Subjects With Stage IIIB or IV Non-Small Cell Lung Cancer (NSCLC) Hot Springs AR 71913
Trial of Ombrabulin (AVE8062) in Combination With Taxane and Platinum in Patients With Non-small Cell Lung Cancer Hot Springs AR 71913
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery Ft. Smith AR 72903
Gemcitabine and Cisplatin in Treating Patients With Stage I Non-Small Cell Lung Cancer That Was Removed by Surgery Ft. Smith AR 72903
Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer Ft. Smith AR 72903
Cancer Vaccine Study for Unresectable Stage III Non-small Cell Lung Cancer Fort Smith AR 72901
Gemcitabine and/or Erlotinib as First-Line Therapy in Treating Older Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Fayetteville AR 72703
Oral HYCAMTIN Plus Whole Brain Radiation Therapy In Treatment Of Brain Metastases Resulting From Non-Small Lung Cancer Fayetteville AR 72703
A Study of Pemetrexed, Carboplatin and Bevacizumab in Patients With Nonsquamous Non-Small Cell Lung Cancer Fayetteville AR 72703
An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene Fayetteville AR 72703
An Investigational Drug, PF-02341066 Is Being Studied Versus Standard Of Care In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene Fayetteville AR 72703
Study of Patients With Advanced Non-Small Cell Lung Cancer Fayetteville AR 72703

Showing 1-100 of 4862
Alabama - Alaska - Arizona - Arkansas - California - Colorado - Connecticut - Delaware - Washington DC - Florida - Georgia - Hawaii - Idaho - Illinois - Indiana - Iowa - Kansas - Kentucky - Louisiana - Maine - Maryland - Massachusetts - Michigan - Minnesota - Mississippi - Missouri - Montana - Nebraska - Nevada - New Hampshire - New Jersey - New Mexico - New York - North Carolina - North Dakota - Ohio - Oklahoma - Oregon - Pennsylvania - Rhode Island - South Carolina - South Dakota - Tennessee - Texas - Utah - Vermont - Virginia - Washington - West Virginia - Wisconsin - Wyoming
For Sponsors: Promote Your Study | For Research Sites: Promote Your Site

Copyright 2012 Clinical Trials Institute, LLC | All Rights Reserved
Login
Forgot password?
Enter your email and we will resend your password
Register